Company Filing History:
Years Active: 2012
Title: Innovations in Drug Delivery: The Contributions of Stephany M Standley
Introduction
Stephany M Standley is an accomplished inventor based in Evanston, IL. She has made significant contributions to the field of drug delivery systems, particularly through her innovative work on acid-degradable polymers. Her research focuses on developing materials that can effectively deliver bioactive substances to cells, enhancing therapeutic applications.
Latest Patents
Stephany M Standley holds a patent for "Main chain acid-degradable polymers for the delivery of bioactive materials." This patent describes novel polymer backbones and drug delivery systems that utilize materials capable of delivering bioactive materials to cells for use as vaccines or other therapeutic agents. The polymers are synthesized using monomers that contain acid-degradable linkages, which can be cleaved under mild acidic conditions. The resulting polymers degrade into small molecules at low pH while remaining stable at physiological pH. This innovative approach allows for the release of therapeutic payloads within cells, particularly in acidic environments such as endosomal or lysosomal compartments. Additionally, these materials can be utilized for delivering therapeutics to acidic regions of tumors and sites of inflammation.
Career Highlights
Stephany M Standley is currently affiliated with the U.S. Department of Energy, where she continues her research and development in the field of polymer science and drug delivery. Her work has garnered attention for its potential applications in medical therapies and vaccine delivery.
Collaborations
Throughout her career, Standley has collaborated with notable scientists, including Jean M J Frechet and Rachna Jain. These collaborations have further enriched her research and contributed to advancements in the field.
Conclusion
Stephany M Standley's innovative work in developing acid-degradable polymers represents a significant advancement in drug delivery systems. Her contributions have the potential to improve therapeutic outcomes and enhance the efficacy of treatments.